{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:53:32Z","timestamp":1791597212791,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The present study aimed at using a proteomics based approach to: a) analyze and contrast the proteome of the healthy and isoproterenol induced hypertrophied hearts and b) identify potential biomarkers for diagnosis of cardiac hypertrophy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Male Sprague Dawley (SD) rats were administered isoproterenol (ISO, 5 mg\/kg, sc, once daily) for 14 days to induce cardiac hypertrophy. There was a significant (p&lt;0.05) increase (~ 55%) in the heart weight to tail length ratio after 14 days of treatment and cardiac hypertrophy was evidenced by significant increase of \u03b2-MHC and ANP, two indicative markers of cardiac hypertrophy, in the treated heart compared to that of control. Following confirmation of hypertrophy, 2DE of the tissue samples was done followed by MS\/MS analysis of the protein spots to obtain a proteomic view for identification of novel biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Several important proteins were identified by proteomics analysis. They belong to the major functional categories such as cholesterol and protein metabolism, muscle contraction and development, transport, TCAcycle, ATP-biosynthesis, chaperone, signal transduction, DNA synthesis and ubiquitinisation. Careful examination of these protein spots by image analysis led to the successful identification of 7 differentially expressed proteins in the diseased sample. Further extension of this work for validation of differential expression of these proteins was also achieved by RTPCR and western blotting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results demonstrate characteristic protein expression profile in control and hypertrophy condition in SD rats and also expand the existing knowledge on differentially expressed proteins in hypertrophy. The study signifies the importance of reduced expression of a novel protein such as Prohibitin (PHB) which may be associated with the cardiomyocytes growth and cardiac hypertrophy. However, further work is necessary to confirm the role of PHB in human heart and its potential role in diagnostic and therapeutic intervention in the clinic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-5876-11-130","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T10:18:30Z","timestamp":1369390710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats"],"prefix":"10.1186","volume":"11","author":[{"given":"Debabrata","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana Devi","family":"Tangutur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak Nath","family":"Khatua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manika Pal","family":"Bhadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"1523_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA: Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000, 102: 470-479. 10.1161\/01.CIR.102.4.470.","journal-title":"Circulation"},{"key":"1523_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ygeno.2003.08.007","volume":"83","author":"CK Yung","year":"2004","unstructured":"Yung CK, Halperin VL, Tomaselli GF, Winslow RL: Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics. 2004, 83: 281-297. 10.1016\/j.ygeno.2003.08.007.","journal-title":"Genomics"},{"key":"1523_CR3","doi-asserted-by":"publisher","first-page":"H8","DOI":"10.1152\/ajpheart.01303.2004","volume":"289","author":"K Berenji","year":"2005","unstructured":"Berenji K, Drazner MH, Rothermel BA, Hill JA: Does load-induced ventricular hypertrophy progress to systolic heart failure?. Am J Physiol Heart Circ Physiol. 2005, 289: H8-H16. 10.1152\/ajpheart.01303.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1523_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.107.098046","volume":"51","author":"D Frank","year":"2008","unstructured":"Frank D, Kuhn C, Brors B, Hanselmann C, L\u00fcdde M, Katus HA, Frey N: Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension. 2008, 51: 309-318. 10.1161\/HYPERTENSIONAHA.107.098046.","journal-title":"Hypertension"},{"key":"1523_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physiolgenomics.90297.2008","volume":"41","author":"A Molojavyi","year":"2010","unstructured":"Molojavyi A, Lindecke A, Raupach A, Moellendorf S, K\u00f6hrer K, G\u00f6decke A: Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. Physiol Genomics. 2010, 41: 137-145. 10.1152\/physiolgenomics.90297.2008.","journal-title":"Physiol Genomics"},{"key":"1523_CR6","first-page":"173","volume":"8","author":"Z Weihua","year":"2003","unstructured":"Weihua Z, Vijayan E, Mohinder SN, Suresh KG, Naranjan SD: Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol. 2003, 8: 173-183.","journal-title":"Exp Clin Cardiol"},{"key":"1523_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","volume":"39","author":"SA Doggrell","year":"1998","unstructured":"Doggrell SA, Brown L: Rat models of hypertension, cardiac hypertrophy and failure. Cardiovas Res. 1998, 39: 89-105. 10.1016\/S0008-6363(98)00076-5.","journal-title":"Cardiovas Res"},{"key":"1523_CR8","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","volume":"113","author":"RS Vasan","year":"2006","unstructured":"Vasan RS: Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006, 113: 2335-2362. 10.1161\/CIRCULATIONAHA.104.482570.","journal-title":"Circulation"},{"key":"1523_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1083\/jcb.200706072","volume":"180","author":"M Schleicher","year":"2008","unstructured":"Schleicher M, Shepherd BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, Acevedo LM, Shadel GS, Sessa WC: Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol. 2008, 180: 101-112. 10.1083\/jcb.200706072.","journal-title":"J Cell Biol"},{"key":"1523_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10741-007-9007-4","volume":"12","author":"OE Osadchii","year":"2007","unstructured":"Osadchii OE: Cardiac hypertrophy induced by sustained \u03b2-adrenoreceptor activation: pathophysiological aspects. Heart Fail Review. 2007, 12: 66-86. 10.1007\/s10741-007-9007-4.","journal-title":"Heart Fail Review"},{"key":"1523_CR11","doi-asserted-by":"publisher","first-page":"e2642","DOI":"10.1371\/journal.pone.0002642","volume":"3","author":"F Ahmad","year":"2008","unstructured":"Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K: The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy. PLoS One. 2008, 3: e2642-10.1371\/journal.pone.0002642.","journal-title":"PLoS One"},{"key":"1523_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK: Change of structural protein during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038\/227680a0.","journal-title":"Nature"},{"key":"1523_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.yjmcc.2010.06.003","volume":"49","author":"SK Banerjee","year":"2010","unstructured":"Banerjee SK, Wang DW, Alzamora R, Huang XN, Pastor-Soler NM, Hallows KR, McGaffin KR, Ahmad F: SGLT1, A novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol. 2010, 49: 683-692. 10.1016\/j.yjmcc.2010.06.003.","journal-title":"J Mol Cell Cardiol"},{"key":"1523_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1152\/physrev.00012.2002","volume":"82","author":"D Fatkin","year":"2002","unstructured":"Fatkin D, Graham RM: Molecular mechanisms of inherited cardiomyopathies. Physiol Rev. 2002, 82: 945-980.","journal-title":"Physiol Rev"},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.exer.2008.06.001","volume":"87","author":"F Wu","year":"2008","unstructured":"Wu F, Lee S, Schumacher M, Jun A, Chakravarti S: Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon. Exp Eye Res. 2008, 87: 214-225. 10.1016\/j.exer.2008.06.001.","journal-title":"Exp Eye Res"},{"key":"1523_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1074\/mcp.M400155-MCP200","volume":"4","author":"TM Casey","year":"2005","unstructured":"Casey TM, Arthur PG, Bogoyevitch MA: Proteomic analysis reveals different protein changes during endothelin-1- or leukemic inhibitory factor-induced hypertrophy of cardiomyocytes in vitro. Mol Cell Proteom. 2005, 4: 651-661. 10.1074\/mcp.M400155-MCP200.","journal-title":"Mol Cell Proteom"},{"key":"1523_CR17","first-page":"1","volume":"2012","author":"SA Paal","year":"2012","unstructured":"Paal SA, Paula LH, Stephen PP, Petros S, Johanna CMS, William JMK, Perry ME, Michael CA: Novel myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity. Biochem Res Intern. 2012, 2012: 1-6.","journal-title":"Biochem Res Intern"},{"key":"1523_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/clc.20832","volume":"34","author":"Y Li","year":"2011","unstructured":"Li Y, Wu G, Tang Q, Huang C, Jiang H, Shi L, Tu X, Huang J, Zhu X, Wang H: Slow cardiac myosin regulatory light chain 2 (MYL2) was down-expressed in chronic heart failure patients. Clin Cardiol. 2011, 34: 30-34. 10.1002\/clc.20832.","journal-title":"Clin Cardiol"},{"key":"1523_CR19","doi-asserted-by":"publisher","first-page":"e28449","DOI":"10.1371\/journal.pone.0028449","volume":"7","author":"M Dhiman","year":"2012","unstructured":"Dhiman M, Zago MP, Nunez S, Amoroso A, Rementeria H, Dousset P, Nunez Burgos F, Garg NJ: Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis. PLoS One. 2012, 7: e28449-10.1371\/journal.pone.0028449.","journal-title":"PLoS One"},{"key":"1523_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s000590050003","volume":"25","author":"NE Bowles","year":"2000","unstructured":"Bowles NE, Bowles KR, Towbin JA: The \u2018final common pathway\u2019 hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz. 2000, 25: 168-175. 10.1007\/s000590050003.","journal-title":"Herz"},{"key":"1523_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1006\/jmcc.1996.0134","volume":"28","author":"JF Collins","year":"1996","unstructured":"Collins JF, Pawloski-Dabree C, Davis MG, Ball N, Dorn GW, Walsh RA: The role of cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol. 1996, 28: 1435-1443.","journal-title":"J Mol Cell Cardiol"},{"key":"1523_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1373\/clinchem.2005.056143","volume":"52","author":"HM Azzazy","year":"2006","unstructured":"Azzazy HM, Pelsers MM, Christenson RH: Unbound free fatty acids and heart-type fatty acid-binding protein; diagnostic assays and clinical applications. Clin Chem. 2006, 52: 19-29. 10.1373\/clinchem.2005.056143.","journal-title":"Clin Chem"},{"key":"1523_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ejheart.2008.06.001","volume":"10","author":"CY Chen","year":"2008","unstructured":"Chen CY, Lee BC, Hsu HC, Lin HJ, Chao CL, Lin YH, Ho YL, Chen MF: A proteomic study of the effects of ramipril on post-infarction left ventricular remodeling in the rabbit. Eu J Heart Fail. 2008, 10: 740-748. 10.1016\/j.ejheart.2008.06.001.","journal-title":"Eu J Heart Fail"},{"key":"1523_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0008-6363(01)00354-6","volume":"51","author":"DS Latchman","year":"2001","unstructured":"Latchman DS: Heat shock proteins and cardiac protection. Cardiovas Res. 2001, 51: 637-646. 10.1016\/S0008-6363(01)00354-6.","journal-title":"Cardiovas Res"},{"key":"1523_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1379\/CSC-272.1","volume":"12","author":"D Giannessi","year":"2007","unstructured":"Giannessi D, Colotti C, Maltinti M, Ry SD, Prontera C, Turchi S, L'Abbate A, Neglia D: Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones. 2007, 12: 265-274. 10.1379\/CSC-272.1.","journal-title":"Cell Stress Chaperones"},{"key":"1523_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cardfail.2005.07.006","volume":"12","author":"T Dohke","year":"2006","unstructured":"Dohke T, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, Horie M: Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Cardiac Fail. 2006, 12: 77-84. 10.1016\/j.cardfail.2005.07.006.","journal-title":"J Cardiac Fail"},{"key":"1523_CR27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.18632\/aging.100234","volume":"2","author":"TJ Schulz","year":"2010","unstructured":"Schulz TJ, Westermann D, Isken F, Voigt A, Laube B, Thierbach R, Kuhlow D, Zarse K, Schomburg L, Pfeiffer AF, Tsch\u00f6pe C, Ristow M: Activation of mitochondrial energy metabolism protects against cardiac failure. Aging (Albany NY). 2010, 2: 843-853.","journal-title":"Aging (Albany NY)"},{"key":"1523_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.tem.2009.04.004","volume":"20","author":"M Artal-Sanz","year":"2009","unstructured":"Artal-Sanz M, Tavernarakis N: Prohibitin and mitochondrial biology. Trends Endocrinol Metab. 2009, 20: 394-401. 10.1016\/j.tem.2009.04.004.","journal-title":"Trends Endocrinol Metab"},{"key":"1523_CR29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.18632\/aging.100246","volume":"2","author":"M Artal-Sanz","year":"2010","unstructured":"Artal-Sanz M, Tavernarakis N: Opposing function of mitochondrial prohibitin in aging. Aging. 2010, 2: 1004-1011.","journal-title":"Aging"},{"key":"1523_CR30","first-page":"1360","volume":"2011","author":"R Ventura-Clapier","year":"1813","unstructured":"Ventura-Clapier R, Garnier A, Veksler V, Joubert F: Review: bioenergetics of the failing heart. Biochim Biophys Acta. 1813, 2011: 1360-1372.","journal-title":"Biochim Biophys Acta"},{"key":"1523_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.niox.2012.03.004","volume":"27","author":"TN Khatua","year":"2012","unstructured":"Khatua TN, Padiya R, Karnewar S, Kuncha M, Agawane SB, Kotamraju S, Banerjee SK: Garlic provides protection to mice heart against isoproterenol-induced oxidative damage: role of nitric oxide. Nitric Oxide. 2012, 27: 9-17. 10.1016\/j.niox.2012.03.004.","journal-title":"Nitric Oxide"},{"key":"1523_CR32","first-page":"1","volume":"21","author":"AL Theiss","year":"2001","unstructured":"Theiss AL, Idell RD, Srinivasan S, Klapproth JM, Jones DP, Merlin D, Sitaraman SV: Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J. 2001, 21: 1-10.","journal-title":"FASEB J"},{"key":"1523_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cvr\/cvq043","volume":"87","author":"KC Lord","year":"2010","unstructured":"Lord KC, Shenouda SK, McIlwain E, Charalampidis D, Lucchesi PA, Varner KJ: Oxidative stress contributes to methamphetamine induced left ventricular dysfunction. Cardiovas Res. 2010, 87: 111-118. 10.1093\/cvr\/cvq043.","journal-title":"Cardiovas Res"},{"key":"1523_CR34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1139\/y2012-068","volume":"90","author":"SK Maulik","year":"2012","unstructured":"Maulik SK, Prabhakar P, Dinda AK, Seth S: Genistein prevents isoproterenol-induced cardiac hypertrophy in rats. Can J Physiol Pharmacol. 2012, 90: 1117-1125. 10.1139\/y2012-068.","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:55:02Z","timestamp":1630540502000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-11-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-11-130","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]},"assertion":[{"value":"14 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"130"}}